IRCTC evidence report
Evidence date: 2026-10-01. Research observations only.
What can I do with this stock?
Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.
Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.
Today: intraday
Evidence unavailable
No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
- No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
Next week: five trading sessions
No qualifying opportunity
No candidate with a primary five-session horizon in the coherent source run.
- No candidate with a primary five-session horizon in the coherent source run.
Long term: one to three years
Research only
A financial screen alone does not establish an investment recommendation.
- A current, source-backed thesis and valuation review is required.
Investment evidence
- Statement coverage
- FULL_STATEMENTS
- Financial source retrieved
- 2026-09-14T13:56:14.138036+00:00
Metrics
- latest_annual_period
- 2026-03-31
- revenue
- 52148631000.0
- net_income
- 13934547000.0
- operating_cash_flow
- 14261896000.0
- free_cash_flow
- 13483346000.0
- total_assets
- 75795216000.0
- total_liabilities
- 32709903000.0
- total_equity
- 43085313000.0
- cash
- 28675234000.0
- total_debt
- 807259000.0
- revenue_growth
- 0.11565194442379956
- earnings_growth
- 0.05974010388452444
- net_margin
- 0.26720829929360945
- roe
- 0.32341756458865695
- debt_to_equity
- 0.01873629187746646
- cash_conversion
- 1.0234919011001937
- free_cash_flow_margin
- 0.25855608750304493
- trailing_pe
- 28.4922
- forward_pe
- 35.5872
- peg_ratio
- Not supplied
- price_to_book
- 9.2096
- dividend_yield
- 0.0183
Other positional research
No qualifying opportunity
No candidate at another positional horizon in the coherent source run.
- No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
- Decision ID
- decision-1ada274fac3ad290c095cf424dc3503f6fb4771458d36afbf3b0769f5a94eaa9
- Policy
- stock-decisions-v1
- Evidence bundle hash
- b124f694efc38b901a38a5ae9fdc6d70534e282b9adcb687a75487b908d3f778
- market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
- validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
- financial-statements: 0e99ce4a2da0cee97d4a54411c96d5aa5cffacd3c301d668d93e7a6767578f83
- daily-price: 43eece892fe16c127f4a8e707acb6257e6677e64a2d828463027e66c34f7ee30
- Conditional research decisions are not orders or personalized position sizes.
- Scenario payoffs are assumptions, not probabilities or expected returns.
- A stop price does not guarantee a maximum loss through a gap or illiquidity.
Download the decision evidence as JSON
Numerical report available. Evidence briefing is queued or awaiting retry.
Cached observations and evidence limits
- Price source verification: REPAIRED.
- The cached closing price on 2026-10-01 was INR 454.10.
- The trailing 5-session price return was -1.54%.
- The trailing 20-session price return was -3.91%.
- The trailing 60-session price return was -8.81%.
- The trailing 250-session price return was -34.52%.
- Average cached traded value over twenty sessions was INR 323,302,062.
- The closing price was -36.99% below its highest close in the available trailing year.
- Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-14T13:56:14.138036+00:00 from EODHD.
- The cached financial metric latest annual period is 2026-03-31.
- The cached financial metric revenue growth is 0.11565194442379956.
- The cached financial metric net margin is 0.26720829929360945.
- The cached financial metric roe is 0.32341756458865695.
- The cached financial metric debt to equity is 0.01873629187746646.
- The cached financial metric cash conversion is 1.0234919011001937.
- The cached financial metric free cash flow margin is 0.25855608750304493.
- Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.